Vyne Therapeutics Inc. · NASDAQ:VYNE
Domzalski David had 14,232 Vyne Therapeutics Inc. shares withheld for tax (Form 4)
Traded Mar 31, 2026 · Filed Apr 2, 2026
On Mar 31, 2026, Domzalski David (Director, PRESIDENT AND CEO) had 14,232 Vyne Therapeutics Inc. shares withheld for tax at US$0.60 for US$8,539, leaving 401,976 shares. Filed Apr 2, 2026 (Form 4).
- Withheld for tax
- 14,232 shares
- Price
- US$0.60
- Value
- US$8,539
- Holding after
- 401,976 shares
- Trading plan
- No
- Role
- Director, PRESIDENT AND CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Common Stock | Shares withheld for tax | 14,232 | US$0.60 | 401,976 | Direct |
Source
Related
- Vyne Therapeutics Inc.
- Domzalski David
- Vyne Therapeutics Inc. shareholders
- Form 4 · Domzalski David · Jul 24, 2026
- Form 4 · Domzalski David · Jul 2, 2026
- Form 4 · Domzalski David · Jun 2, 2026
- Form 4 · Zeronda Tyler · Jul 24, 2026
- Form 4 · Stuart Iain · Jul 24, 2026
- Form 4 · Harsch Mutya · Jul 24, 2026
- Schedule 13G/A · Zhang Xiaofan · Jul 17, 2026
- Schedule 13G/A · Zhang Xiaofan · Jul 14, 2026